본문바로가기
Q
U
I
C
K

Business

SK bioscience’s effort reaches beyond development and manufacture of premium vaccines
and extends to working with domestic and overseas partners to create a healthy future for mankind.

In-house Products

SKY Typhoid Multi Inj. 사진

SKY Typhoid Multi Inj.

(Thyphoid purified Vi Polysaccharide Conjugated to Diphtheria toxoid vaccine)

  • Classification Prescription medicine
  • Therapeutics classificationTyphoid vaccine
  • Ingredients/contentTyphoid Vi Polysaccharide Conjugated to Diphtheria Toxoid (In-house)
Appearance

Clear colorless liquid contained within colorless and transparent vial

Indications

Active immunization for the prevention of typhoid fever caused by Salmonella Typhi in age of ≥ 6 months and ≤ 45 years

Description
  • SKYTyphoid Multi Inj. is a clear colorless liquid containing purified Vi polysaccharide of Salmonella Typhi which is conjugated to carrier protein, Diphtheria Toxoid.
  • SKYTyphoid Multi Inj. contains 5mg/dose 2-Phenoxyethanol as preservative.
Dosage and schedule

Inject 0.5mL intramuscularly. SKYTyphoid Multi Inj. should be given intramuscularly in the deltoid region of subjects. For children aged  ≥ 6 months to < 2 years, it can be given intramuscularly in anterolateral thigh.

Instruction for administration
  • 1. Inspect the vaccine visually for any particulate matter or change in physical appearance prior to administration.
  • 2. Do not administer SKYTyphoid Multi Inj. via intravenous injection
  • 3. Lateral upper arm is the typical administration site and should be disinfected with ethanol or iodine tincture before the administration. In addition, it is advised to avoid repeating vaccination at the same site.
How supplied

2.5mL/vial x 10

Storage

Keep refrigerated at 2℃ to 8℃ in a hermetic container away from light. Do NOT freeze.